SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

In 2001, a woman was dragged into a Pacific Beach alley and sexually assaulted at knifepoint. It took more than 20 years to ...

In honor of Rare Disease Day on February 28, 2025, Morgan Lewis is publishing a series of posts on As Prescribed and Health ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Five witnesses have testified in day two of the State v. James F. Wilson jury trial. The victim who was 17 at the time of her ...

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

The Oxford Police Department and the Carroll County Sheriff's Office confirmed on Wednesday that human remains found last ...

Chrisean Rock has sparked controversy after posting her son’s paternity test results on February 5, just days after the ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

In 1972, the quiet community of Vernal, Utah, was shaken by a violent crime that remained unsolved for more than 50 ...